The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
Abstract
Background Clinical trials in children are being encouraged by regulatory authorities in light of the immense off-label and unlicensed use of drugs in the paediatric population. The use of in silico techniques for pharmacokinetic prediction will aid in the development of paediatric clinical trials by guiding dosing regimens, ensuring efficient blood sampling times, maximising therapeutic effect and potentially reducing the number of children required for the study. The goal of this study was to extend an existing physiologically based pharmacokinetic (PBPK) model for adults to reflect the age-related physiological changes in children from birth to 18 years of age and, in conjunction with a previously developed age-specific clearance model, to evaluate the accuracy of the paediatric PBPK model to predict paediatric plasma profiles.Methods The age-dependence of bodyweight, height, organ weights, blood flows, interstitial space and vascular space were taken from the literature. Physiological parameters that were used in the PBPK model were checked against literature values to ensure consistency. These included cardiac output, portal vein flow, extracellular water, total body water, lipid and protein. Five model compounds (paracetamol [acetaminophen], alfentanil, morphine, theophylline and levofloxacin) were then examined by gathering the plasma concentration-time profiles, volumes of distribution and elimination half-lives from different ages of children and adults. First, the adult data were used to ensure accurate prediction of pharmacokinetic profiles. The model was then scaled to the specific age of children in the study, including the scaling of clearance, and the generated plasma concentration profiles, volumes of distribution and elimination half-lives were compared with literature values.Results Physiological scaling produced highly age-dependent cardiac output, portal vein flow, extracellular water, total body water, lipid and protein values that well represented literature data. The pharmacokinetic profiles in children for the five compounds were well predicted and the trends associated with age were evident. Thus, young neonates had plasma concentrations greater than the adults and older children had concentrations less than the adults. Eighty-three percent, 97% and 87% of the predicted plasma concentrations, volumes of distribution and elimination half-lives, respectively, were within 50% of the study reported values. There was no age-dependent bias for term neonates to 18 years of age when examining volumes of distribution and elimination half-lives.Conclusion This study suggests that the developed paediatric PBPK model can be used to scale pharmacokinetics from adults. The accurate prediction of pharmacokinetic parameters in children will aid in the development of dosing regimens and sampling times, thus increasing the efficiency of paediatric clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generalization beyond healthy adults requires explicit consideration of physiological diversity that simple allometric scaling cannot capture [22,87,88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [88]
In the citing paper
“Population PBPK models that embed age-dependent physiology (organ volumes, blood flows, enzyme expression, and renal function) can simulate pediatric exposures and justify bridging strategies based on adult data [22,88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [88]
In the citing paper
“Pediatric dosing should incorporate enzyme and transporter ontogeny rather than rely on simple weight- or BSA-based exponents [88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [88]
In the citing paper
“CYP3A4, for example, matures over the first year of life, while CYP1A2 and CYP2D6 exhibit distinct developmental trajectories.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [88]
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 1,754
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Body composition of reference children from birth to age 10 years
Fomon, S., Haschke, F., Ziegler, E., & Nelson, S. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/35.5.1169 · Cited by 1,268
Survey of unlicensed and off label drug use in paediatric wards in European countries
Conroy, S. (2000) · BMJ · doi:10.1136/bmj.320.7227.79 · Cited by 735
Body composition of the reference fetus.
Ziegler, E. E., O'Donnell, A. M., Nelson, S. E., & Fomon, S. J. (1976) · PubMed · Cited by 713
Basic anatomical and physiological data for use in radiological protection : reference values
Valentin, J. (2002) · Medical Entomology and Zoology · Cited by 680
Greenway, C. V., & Stark, R. D. (1971) · Physiological Reviews · doi:10.1152/physrev.1971.51.1.23 · Cited by 633
Poulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
The Clinical Pharmacokinetics of Levofloxacin
Fish, D. N., & Chow, A. T. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732020-00002 · Cited by 475
Research works printed but not linked: 6
- Raynaud, 1990, J Nucl Med, 31S, 892
- Goetzova, 1977, Cor Vasa, 19, 161
- Lopez Barrio, 1996, An Esp Pediatr, 44, 45
- Cecchetti, 2003, Minerva Anestesiol, 69, 907
- Zeigler, 1976, Growth, 40, 329
- Vichyanond, 1994, Asian Pac J Allergy Immunol, 12, 137
Cited by
Kleinman, M. E., Chameides, L., Schexnayder, S. M., Samson, R. A., Hazinski, M. F., Atkins, D. L., Berg, M. D., de Caen, A. R., Fink, E. L., Freid, E. B., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971101 · Cited by 1,949
Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
Anderson, B. J., & Holford, N. H. G. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094708 · Cited by 1,125
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Berg, M. D., Schexnayder, S. M., Chameides, L., Terry, M., Donoghue, A., Hickey, R. W., Berg, R. A., Sutton, R. M., & Hazinski, M. F. (2010) · Pediatrics · doi:10.1542/peds.2010-2972c · Cited by 398
Metadata
- Authors
- Edginton, A. N., Schmitt, W., & Willmann, S.
- Affiliations
- Bayer (Germany) (DE)
- Corresponding author
- Edginton, Andrea N
- Venue
- Clinical Pharmacokinetics
- Published
- 2006
- Volume
- 45
- Issue
- 10
- Pages
- 1013-1034
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W1984452104
- Cited by
- 357
- References
- 108
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 19 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 19 · 2019: 27 · 2018: 25 · 2017: 17 · 2016: 12 · 2015: 15 · 2014: 19 · 2013: 16 · 2012: 20
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- pediatric pharmacokinetics, physiologically based pharmacokinetic modeling, age-related physiological changes, plasma concentration-time curve, paracetamol, alfentanil, morphine, theophylline, levofloxacin, neonates, pediatric dosing
- MeSH terms
- Adolescent, Aging, Algorithms, Blood Volume, Body Height, Body Weight, Chemistry, Physical, Child, Child, Preschool, Computer Simulation, Humans, Infant, Infant, Newborn, Pharmacokinetics, Regional Blood Flow, Tissue Distribution, Models, Statistical, Bias, Area Under Curve, Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children. https://app.cochat.ai/papers/10.2165/00003088-200645100-00005
- The paper
- Edginton, A. N., Schmitt, W., & Willmann, S. (2006). Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200645100-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.